Alper Biotech, LLC
Records under this name other than patents Alper Biotech, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,753,829 | Monoclonal antibodies against HER2 antigens, and uses therefor Lapsed on the fee record Ended Jun 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 17, 2022 | From the USPTO record |
| US 8,722,362 | Monoclonal antibodies against HER2 antigens, and uses therefor Lapsed on the fee record Ended May 13, 2022 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2022 | From the USPTO record |
| US 8,703,441 | Monoclonal antibodies against PCBP-1 antigens, and uses therefor Lapsed on the fee record Ended Apr 22, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2022 | From the USPTO record |
| US 9,840,560 | Monoclonal antibodies to EGFR, and uses therefor Lapsed on the fee record Ended Dec 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2021 | From the USPTO record |
| US 8,540,991 | Monoclonal antibodies against PCBP-1 antigens, and uses therefor Lapsed on the fee record Ended Sep 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2021 | From the USPTO record |
| US 8,519,104 | Monoclonal antibodies against GMF-B antigens, and uses therefor Lapsed on the fee record Ended Aug 27, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2021 | From the USPTO record |
| US 9,663,567 | Monoclonal Antibodies Against Serotransferrin Antigens, and Uses Therefor Lapsed on the fee record Ended May 30, 2021 · High confidence | Lapsed on the fee record | Ended May 30, 2021 | High confidence |
| US 8,349,585 | Monoclonal antibodies against HER2 antigens, and uses therefor Lapsed on the fee record Ended Jan 8, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 8, 2021 | From the USPTO record |
| US 9,448,239 | Monoclonal antibodies against PCBP-1 antigens, and uses therefor Lapsed on the fee record Ended Sep 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2020 | From the USPTO record |
| US 9,040,043 | Monoclonal antibodies against GMF-B antigens, and uses therefor Lapsed on the fee record Ended May 26, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 26, 2019 | From the USPTO record |